Pharmaceutical and In-vitro Diagnostics Spend Analysis 2018 - 2019

Pharmaceutical Spend Analysis 2019

Publication Date: November 2020

Download

The Procurement Services Branch (PSB) performs an annual analysis of UNFPA Pharmaceutical and In-vitro Diagnostics Spend  spend.

Related content

Updates
UNFPA is pleased to invite Manufacturers of Reproductive Health Medicines to submit an Expression of Interest (EOI) for product evaluation by WHO Expert Review Panel (ERP) regarding RH medicines.
Resources
UNFPA is seeking to improve the environmental sustainability of all aspects of its procurement activities. See the results of our greening condom procurement activities in 2018.
Resources
To respond to unplanned pregnancies costs the country 5.4 times more than preventing it. By partnering with UNFPA, Ecuador saves up to 17 dollars for every dollar invested in sexual and reproductive health.

Pages

We use cookies and other identifiers to help improve your online experience. By using our website you agree to this. To learn more, including how to change your settings, see our cookies policy.

X